Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential

Cancer Biology and Therapy

Volumn 15, Issue 2, 2014, Pages 216-224

  Stockhausen, Marie Thérése ^a   Kristoffersen, Karina ^a   Stobbe, Louise ^a   Poulsen, Hans Skovgaard ^a  

^a FINSEN LABORATORY   (Denmark)

Author keywords

Differentiation; EGFR; EGFRvIII; Glioblastoma multiforme

Indexed keywords

DIFFERENTIATION; EGFR; EGFRVIII; GLIOBLASTOMA MULTIFORME;

ANIMALS; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CULTURE MEDIA, SERUM-FREE; DOWN-REGULATION; GLIOBLASTOMA; HETEROGRAFTS; HUMANS; MICE; NEOPLASTIC STEM CELLS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRETINOIN;

EID: 84894516200     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.26736     Document Type: Article

References (47)

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al.; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-96; PMID: 15758009; http://dx.doi.org/10.1056/NEJMoa043330 (Pubitemid 40349501)
2. Ekstrand AJ, Longo N, Hamid ML, Olson JJ, Liu L, Collins VP, James CD. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene 1994; 9: 2313-20; PMID: 8036013 (Pubitemid 24228682)
3. Huang HS, Nagane M, Klingbeil CK, Lin H, Nishikawa R, Ji XD, Huang CM, Gill GN, Wiley HS, Cavenee WK. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J Biol Chem 1997; 272: 2927-35; PMID: 9006938; http://dx.doi.org/10. 1074/jbc.272.5.2927 (Pubitemid 27053343)
4. Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, Huang HJ. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci U S A 1994; 91: 7727-31; PMID: 8052651; http://dx.doi.org/10.1073/pnas.91.16.7727 (Pubitemid 24238258)
5. Shinojima N, Tada K, Shiraishi S, Kamiryo T, Kochi M, Nakamura H, Makino K, Saya H, Hirano H, Kuratsu J, et al. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res 2003; 63: 6962-70; PMID: 14583498 (Pubitemid 37322983)
6. Torp SH, Helseth E, Dalen A, Unsgaard G. Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas. Acta Neurochir (Wien) 1992; 117: 182-6; PMID: 1414519; http://dx.doi.org/10.1007/BF01400618
7. Lassman AB, Rossi MR, Raizer JJ, Abrey LE, Lieberman FS, Grefe CN, Lamborn K, Pao W, Shih AH, Kuhn JG, et al. Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01. Clin Cancer Res 2005; 11: 7841-50; PMID: 16278407; http://dx.doi.org/10.1158/1078-0432.CCR-05- 0421 (Pubitemid 41611629)
8. Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, Lu KV, Yoshimoto K, Huang JH, Chute DJ, et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 2005; 353: 2012-24; PMID: 16282176; http://dx.doi.org/10.1056/NEJMoa051918 (Pubitemid 41609094)
9. Rich JN, Reardon DA, Peery T, Dowell JM, Quinn JA, Penne KL, Wikstrand CJ, Van Duyn LB, Dancey JE, McLendon RE, et al. Phase II trial of gefitinib in recurrent glioblastoma. J Clin Oncol 2004; 22: 133-42; PMID: 14638850; http://dx.doi.org/10.1200/JCO.2004.08.110 (Pubitemid 41095125)
10. Bigner SH, Humphrey PA, Wong AJ, Vogelstein B, Mark J, Friedman HS, Bigner DD. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res 1990; 50: 8017-22; PMID: 2253244
11. Pandita A, Aldape KD, Zadeh G, Guha A, James CD. Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. Genes Chromosomes Cancer 2004; 39: 29-36; PMID: 14603439; http://dx.doi.org/10.1002/ gcc.10300 (Pubitemid 37475250)
12. Stockhausen MT, Broholm H, Villingshøj M, Kirchhoff M, Gerdes T, Kristoffersen K, Kosteljanetz M, Spang-Thomsen M, Poulsen HS. Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme. Exp Cell Res 2011; 317: 1513-26; PMID: 21514294; http://dx.doi.org/10.1016/j.yexcr.2011.04.001
13. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9: 391-403; PMID: 16697959; http://dx.doi.org/10.1016/j.ccr.2006.03.030 (Pubitemid 43668737)
14. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F, Vescovi A. Isolation and characterization of tumorigenic, stemlike neural precursors from human glioblastoma. Cancer Res 2004; 64: 7011-21; PMID: 15466194; http://dx.doi.org/10.1158/0008-5472.CAN-04- 1364 (Pubitemid 39331011)
15. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002; 39: 193-206; PMID: 12203386; http://dx.doi.org/10.1002/glia.10094
16. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-8; PMID: 14522905 (Pubitemid 37187480)
17. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401; PMID: 15549107; http://dx.doi.org/10.1038/ nature03128 (Pubitemid 39551674)
18. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann- Hogiu S, Farkas DL, Black KL, Yu JS. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004; 23: 9392-400; PMID: 15558011; http://dx.doi.org/10.1038/sj.onc. 1208311 (Pubitemid 40069671)
19. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756-60; PMID: 17051156; http://dx.doi.org/10.1038/nature05236 (Pubitemid 44949604)
20. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD, Rich JN. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006; 66: 7843-8; PMID: 16912155; http://dx.doi.org/10.1158/0008-5472.CAN-06-1010 (Pubitemid 44299144)
21. Lathia JD, Gallagher J, Myers JT, Li M, Vasanji A, McLendon RE, Hjelmeland AB, Huang AY, Rich JN. Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells. PLoS One 2011; 6:e24807; PMID: 21961046; http://dx.doi.org/10.1371/journal.pone.0024807
22. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006; 5: 67; PMID: 17140455; http://dx.doi.org/10.1186/1476-4598-5-67
23. Massard C, Deutsch E, Soria JC. Tumour stem celltargeted treatment: elimination or differentiation. Ann Oncol 2006; 17: 1620-4; PMID: 16600978; http://dx.doi.org/10.1093/annonc/mdl074 (Pubitemid 44680880)
24. Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 2004; 51: 1-28; PMID: 15207251; http://dx.doi.org/10.1016/j. critrevonc.2004.04.007 (Pubitemid 38781748)
25. Kristoffersen K, Villingshøj M, Poulsen HS, Stockhausen MT. Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures. Cancer Biol Ther 2013; 14: 625-37; PMID: 23792644; http://dx.doi.org/10.4161/cbt.24595
26. Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE, Ahmadi R, Lohr J, Dictus C, Gdynia G, et al. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 2010; 16: 2715-28; PMID: 20442299; http://dx.doi.org/10.1158/1078-0432.CCR-09-1800
27. Ying M, Wang S, Sang Y, Sun P, Lal B, Goodwin CR, Guerrero-Cazares H, Quinones-Hinojosa A, Laterra J, Xia S. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. Oncogene 2011; 30: 3454-67; PMID: 21383690; http://dx.doi.org/10.1038/onc.2011.58
28. Engstrom CM, Demers D, Dooner M, McAuliffe C, Benoit BO, Stencel K, Joly M, Hulspas R, Reilly JL, Savarese T, et al. A method for clonal analysis of epidermal growth factor-responsive neural progenitors. J Neurosci Methods 2002; 117: 111-21; PMID: 12100976; http://dx.doi.org/10.1016/S0165-0270(02)00074-2 (Pubitemid 34718158)
29. Mori H, Ninomiya K, Kino-oka M, Shofuda T, Islam MO, Yamasaki M, Okano H, Taya M, Kanemura Y. Effect of neurosphere size on the growth rate of human neural stem/progenitor cells. J Neurosci Res 2006; 84: 1682-91; PMID: 17044035; http://dx.doi.org/10.1002/jnr.21082 (Pubitemid 44892602)
30. Joo KM, Kim SY, Jin X, Song SY, Kong DS, Lee JI, Jeon JW, Kim MH, Kang BG, Jung Y, et al. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 2008; 88: 808-15; PMID: 18560366; http://dx.doi.org/10.1038/labinvest.2008.57
31. Piccirillo SG, Combi R, Cajola L, Patrizi A, Redaelli S, Bentivegna A, Baronchelli S, Maira G, Pollo B, Mangiola A, et al. Distinct pools of cancer stemlike cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution. Oncogene 2009; 28: 1807-11; PMID: 19287454; http://dx.doi.org/10.1038/onc.2009.27
32. Kukekov VG, Laywell ED, Suslov O, Davies K, Scheffler B, Thomas LB, O'Brien TF, Kusakabe M, Steindler DA. Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp Neurol 1999; 156: 333-44; PMID: 10328940; http://dx.doi.org/10.1006/exnr.1999. 7028 (Pubitemid 29205008)
33. Lee A, Kessler JD, Read TA, Kaiser C, Corbeil D, Huttner WB, Johnson JE, Wechsler-Reya RJ. Isolation of neural stem cells from the postnatal cerebellum. Nat Neurosci 2005; 8: 723-9; PMID: 15908947; http://dx.doi.org/10.1038/nn1473 (Pubitemid 43085837)
34. Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, Berger MS. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol 2007; 9: 424-9; PMID: 17622647; http://dx.doi.org/10.1215/15228517-2007-023
35. Weickert CS, Webster MJ, Colvin SM, Herman MM, Hyde TM, Weinberger DR, Kleinman JE. Localization of epidermal growth factor receptors and putative neuroblasts in human subependymal zone. J Comp Neurol 2000; 423: 359-72; PMID: 10870078; http://dx.doi.org/10.1002/1096-9 8 6 1 ( 2 0 0 0 0 7 3 1 ) 4 2 3 : 3 3.0.CO;2-0 (Pubitemid 30451671)
36. Aguirre A, Rubio ME, Gallo V. Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal. Nature 2010; 467: 323-7; PMID: 20844536; http://dx.doi.org/10.1038/nature09347
37. Ayuso-Sacido A, Moliterno JA, Kratovac S, Kapoor GS, O'Rourke DM, Holland EC, García-Verdugo JM, Roy NS, Boockvar JA. Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells. J Neurooncol 2010; 97: 323-37; PMID: 19855928; http://dx.doi.org/10.1007/s11060-009-0035-x
38. Boockvar JA, Kapitonov D, Kapoor G, Schouten J, Counelis GJ, Bogler O, Snyder EY, McIntosh TK, O'Rourke DM. Constitutive EGFR signaling confers a motile phenotype to neural stem cells. Mol Cell Neurosci 2003; 24: 1116-30; PMID: 14697673; http://dx.doi.org/10.1016/j.mcn.2003.09.011 (Pubitemid 38091521)
39. Mazzoleni S, Politi LS, Pala M, Cominelli M, Franzin A, Sergi Sergi L, Falini A, De Palma M, Bulfone A, Poliani PL, et al. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res 2010; 70: 7500-13; PMID: 20858720; http://dx.doi.org/10.1158/0008-5472.CAN-10-2353
40. Howard BM, Gursel DB, Bleau AM, Beyene RT, Holland EC, Boockvar JA. EGFR signaling is differentially activated in patient-derived glioblastoma stem cells. J Exp Ther Oncol 2010; 8: 247-60; PMID: 20734923
41. Del Vecchio CA, Jensen KC, Nitta RT, Shain AH, Giacomini CP, Wong AJ. Epidermal growth factor receptor variant III contributes to cancer stem cell phenotypes in invasive breast carcinoma. Cancer Res 2012; 72: 2657-71; PMID: 22419663; http://dx.doi.org/10.1158/0008-5472.CAN-11-2656
42. Wong A, Mitra S, Del Vecchio CA, Shirboll S. Expression of EGFRvIII in brain tumor stem cells. J Clin Oncol 2012; 26: 15s
43. Liu XJ, Wu WT, Wu WH, Yin F, Ma SH, Qin JZ, Liu XX, Liu YN, Zhang XY, Li P, et al. A minority subpopulation of CD133(+) /EGFRvIII(+) /EGFR(-) cells acquires stemness and contributes to gefitinib resistance. CNS Neurosci Ther 2013; 19: 494-502; PMID: 23575351; http://dx.doi.org/10.1111/cns.12092
44. Dirks PB. Brain tumor stem cells: bringing order to the chaos of brain cancer. J Clin Oncol 2008; 26: 2916-24; PMID: 18539973; http://dx.doi.org/10. 1200/JCO.2008.17.6792
45. Soeda A, Inagaki A, Oka N, Ikegame Y, Aoki H, Yoshimura S, Nakashima S, Kunisada T, Iwama T. Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J Biol Chem 2008; 283: 10958-66; PMID: 18292095; http://dx.doi.org/10.1074/jbc.M704205200
46. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, et al. Molecular subclasses of highgrade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006; 9: 157-73; PMID: 16530701; http://dx.doi.org/10.1016/j.ccr.2006.02.019 (Pubitemid 43357943)
47. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al.; Cancer Genome Atlas Research Network. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010; 17: 98-110; PMID: 20129251; http://dx.doi.org/10.1016/j.ccr. 2009.12.020